59263-35-3

Upstream product

• 100-39-0 benzyl bromide 
• 75795-58-3 4-O-(3,4-O-isopropylidene-β-D-galactopyranosyl)-D-glucopyranose 
• 18404-73-4 (2R,3R,4R,5S,6R)-2-(benzyloxy)-5-(((3aS,4R,6S,7R,7aR)-7-hydroxy-4-(hydroxymethyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol 
• 18404-72-3 benzyl 4-O-β-D-galactopyranosyl-β-D-glucopyranoside 
• 77-76-9 2,2-dimethoxy-propane 
• 100-44-7 benzyl chloride 
• 70223-97-1 2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1->4)-2,3,6-tri-O-acetyl-β-D-glucopyranosyl bromide 
• 67310-53-6 (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-(((2R,3R,4S,5R,6R)-4,5-diacetoxy-2-(acetoxymethyl)-6-(benzyloxy)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
• 3616-19-1 1',2',3',6',2,3,4,6-octa-O-acetyl-β-D-lactose 

Downstream Products

• 94926-36-0 benzyl 2,3,6-tri-O-benzyl-4-O-(2,6-di-O-benzyl-β-D-galactopyranosyl)-β-D-glucopyranoside 
• 62867-79-2 benzyl O-(2,3,6-tri-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside 
• 121845-01-0 Benzyl O-(3-O-allyl-2,6-di-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside 
• 121237-39-6 (2R,3R,4S,5R,6S)-5-(benzyloxy)-2-((benzyloxy)methyl)-4-hydroxy-6-(((2R,3R,4S,5R,6R)-4,5,6-tris(benzyloxy)-2-((benzyloxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3-yl acetate 
• 101068-01-3 benzyl-2,3,6,2',6'-penta-O-benzyl-3'-O--β-D-lactoside 
• 96520-23-9 benzyl [methyl (4''',5''',7''',8''',9'''-penta-O-acetyl-β-neuramin)ate]yl-(2'''->3'')-2'',6''-di-O-benzyl-β-galactopyranosyl-(1''->4')-2',3',6'-tri-O-benzyl-β-glucopyranoside 
• 96520-22-8 benzyl O--(2->3)-O-(2,6-di-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside 
• 96520-24-0 C₆₅H₇₅NO₁₉ 
• 96520-25-1 C₆₅H₇₅NO₁₉ 

Relevant academic research and scientific papers

Synthesis of lacto-N-tetraose

Human milk oligosaccharides (HMOs) are the third largest macromolecular component of breast milk and offer infants numerous health benefits, most of which stem from the development of a healthy microbiome. Characterization, quantification, and chemical de

The total synthesis of ganglioside GM3

Previous syntheses of ganglioside GM3 (NeuAcα3Galβ4Glcβ1Cer) are reviewed, and both chemoenzymatic and chemical total synthetic approaches were investigated. In a chemoenzymatic approach, (2S,3R,4E)-5'''-acetyl-α-neuraminyl-(2''' → 3'')-β-galactopyranosyl-(1'' → 4')-β-glucopyranosyl-(1' mutually implies 1)-2-azido-4-octadecene-1,3-diol (azidoGM3) was readily prepared utilizing recombinant β-Gal-(1'' → 3'/4')-GlcNAc α-(2''' → 3'')-sialyltransferase enzyme, and was evaluated as a synthetic intermediate to ganglioside GM3. The chemical total synthesis of ganglioside GM3 was performed on one of the largest scales yet reported. The highlights of this synthesis include minimizing the steps necessary to prepare the lactosyl acceptor as a useful anomeric mixture, which was present in excess for the highly regioselective and fairly stereoselective sialylation with a known neuraminyl donor to give the protected GM3 trisaccharide. The synthetic methodology maximized convergence by a subsequent glycosidic coupling of the well-characterized GM3 trisaccharide trichloroacetimidate derivative with protected ceramide. The ganglioside GM3 was nearly homogeneous as the two glycosidic couplings utilized preparative HLPC purifications, and variations in the sphingosine base and fatty acyl group were under 0.1 and 0.2%, respectively. (C) 2000 Elsevier Science Ltd.

Glycosyl imidates, 74: Synthesis of ganglioside GM1 via a GM3 intermediate

The synthesis of GM1 (1) via GM3 intermediate 7 was based on lactose building-block 5, sialyl donors 6, and a Galβ(1-3)-GalN3 donor 13α. Reaction of donor 13α with acceptor 7 in the presence of TMSOTf as catalyst afforded GM1 pentasaccharide 30. Azido group reduction, N-acetylation, hydrogenolytic O-debenzylation, and O-acetylation furnished O-acyl-protected GM1 pentasaccharide 34. Chemoselective 1a-O-deacetylation and generation of O-(pentaosyl)trichloroacetimidate 36 provided the required glycosyl donor for the application to azidosphingosine glycosylation procedure affording GM1 (1). VCH Verlagsgesellschaft mbH, 1996.

Glycosyl Imidates, 42.- Selectively Protected Lactose and 2-Azido Lactose, Building Blocks for Glycolipid Synthesis

Performing regioselective alkylation at 3'-OH of benzyl β-lactoside 1 by the stannylation method we prepared the 3'-OH- and 4'-OH-unprotected lactose derivatives 5 and 10 and the 4'-OH-unprotected lactose derivative 9 containing a different protecting gro

Total synthesis of globotriaosyl-E and Z-ceramides and isoglobotriaosyl-E-ceramide.

Stereoselective, total synthesis of O-alpha-D-galactopyranosyl-(1----4) -O-beta-D-galactopyranosyl-(1----4)-O-beta-D-glucopyranosyl-(1----1)-N -tetracosanoyl-[2S,3R,4E (and 4Z)]-sphingenine and O-alpha-D -galactopyranosyl-(1----3)-O-beta-D-galactopyranosyl-(1----4)-O-beta-D -glucopyranosyl-(1----1)-N-tetracosanoyl-(2S,3R,4E)-sphin gen ine was achieved by using O-(2,3,4,6-tetra-O-acetyl-alpha-D-galactopyranosyl) -(1----4)-O-(2,3,6-tri-O-acetyl-beta-D-galactopyranosyl)-(1----4)-2,3,6- tri-O-acetyl-alpha-D-glucopyranosyl trichloroacetimidate, O-(2,3,4,6-tetra-O-acetyl-alpha-D-galactopyranosyl) -(1----4)-O-(2,3,6-tri-O-acetyl-beta-D-galactopyranosyl)-(1----4)-2,3,6- tri-O-acetyl-alpha (and beta)-D-glucopyranosyl fluoride, and O-(2,3,4,6-tetra-O-acetyl-alpha-D -galactopyranosyl)-(1----3)-O-(2,3,6-tri-O-acetyl-beta-D-galactopyran osyl)-(1----4)-2,3,6-tri-O-acetyl-alpha-D-glucopyranosyl trichloroacetimidate.